doxorubicin

Sun Pharma is pulling one lot of a chemotherapy drug in the U.S. as the issue of particulate contamination crops up once more for a manufacturer.

Fraiser Kansteiner May 14, 2026 8:35am

Jul 5, 2022 9:03am